Borealis Ventures

Borealis Ventures investment thesis

top of page ABOUT TEAM PORTFOLIO NEWS CONTACT More Use tab to navigate through the menu items. 2002 Firm Founded Therapeutic 300+ Programs >$8b Value Created ABOUT BOREALIS Borealis Ventures partners closely with exceptional entrepreneurs to build market-defining companies. Our focus is on the extraordinary opportunities to transform healthcare through new therapies, digital innovation, and other technologies. Our former Built Environment investing team now operates as Building Ventures . With a legacy of advancing entrepreneurship at Dartmouth College, we bring our experience of investing at the earliest stages to emerging companies across the U.S. and beyond. Meet Our Team TRANSFORMING THE FUTURE OF HEALTHCARE CONTACT US For any inquiries, please call or email us: 603.643.1500   | team@b

Borealis Ventures team (5)

Partners and principals at Borealis Ventures:

• Charlie Carey — sweet spot $500K
• Phil Ferneau — sweet spot $500K
• Benjamin Shaw — sweet spot $500K
• Emily Snyder — sweet spot $500K
• Julia Stephanus — sweet spot $500K

Borealis Ventures portfolio companies

Companies listed on Borealis Ventures's public materials include: ABOUT, TEAM, PORTFOLIO, NEWS, More, OUR PORTFOLIO, Acquired by Glaukos, Acquired by Repligen, Merged with Wedgewood, NASDAQ: CMPX, NASDAQ: CVET, Acquired by Merck, Acquired by Altaris, team@borealis.vc.

Is Borealis Ventures a fit for your round?

Upload your pitch deck and see whether anyone at Borealis Ventures appears in your top matches.